Sarah M. Churchman

Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

Benazir Saleem, Helen Keen, Vincent Goëb et al. · Annals of the Rheumatic Diseases · 2010 · 200 citations

Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment

Rebeccah J. Mathews, James Robinson, M. Battellino et al. · Annals of the Rheumatic Diseases · 2013 · 194 citations

Large‐scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: Implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells

Elena Jones, Anne English, Sarah M. Churchman et al. · Arthritis & Rheumatism · 2010 · 166 citations

Induced periosteum a complex cellular scaffold for the treatment of large bone defects

Richard Cuthbert, Sarah M. Churchman, Hiang Boon Tan et al. · Bone · 2013 · 159 citations

Tissue Engineering, Regenerative Medicine, Engineering +12

Transcriptional profile of native CD271+ multipotential stromal cells: Evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activity

Sarah M. Churchman, Frédérique Ponchel, Sally Boxall et al. · Arthritis & Rheumatism · 2012 · 135 citations